Literature DB >> 21939711

Adolescents' awareness of HPV infections and attitudes towards HPV vaccination 3 years following the introduction of the HPV vaccine in Hungary.

Erika Marek1, Timea Dergez, Gabor Rebek-Nagy, Antal Kricskovics, Krisztina Kovacs, Szabolcs Bozsa, Istvan Kiss, Istvan Ember, Peter Gocze.   

Abstract

Hungary takes the fourth place regarding the incidence and the fifth regarding the mortality of cervical cancer among the member countries of the European Union, with 500 deaths due to this preventable illness and nearly 1200 new cases diagnosed every year. Although the vaccines have been available for 3 years, the estimated rate of the female population vaccinated against HPV is approximately 10% in the 12-26-year-age cohort. The aim of this study was to determine factors and motivations affecting the uptake of HPV vaccination among Hungarian adolescents. Examining the effects of some possible sociodemographic predictors (age and gender) and the exposure to health information on HPV vaccine acceptability were also focused on, as well as assessing the most trusted sources of information about sexually transmitted diseases (STDs). A nationwide anonymous questionnaire survey with a sample of 1769 students attending public primary or secondary schools was organised by the authors in 16 Hungarian cities and towns. Data were analysed using the Statistical Package for the Social Sciences (SPSS). Adolescents' awareness of HPV was relatively low. Only 35% of the participants reported they had heard about HPV prior to the survey. Almost 70% of the potentially affected study population had not heard about the vaccine previously. Every fourth student did not believe that vaccination against HPV can prevent cervical cancer. If the vaccination was available free of charge, almost 80% of respondents would request it, but in case they had to pay for it, this number would significantly decrease. Significantly better knowledge and also more positive attitudes towards HPV vaccination was found in relation to the number of information sources. The majority of respondents (62-83%) were open for further information about STDs. The main trusted mediators were school-health services (61.3%), education on health at school (49.2%), health professionals (42.2%) and electronic media (24.6%). Since Hungarian adolescent students expect guidance about STDs principally from school health education, an urgent need for well-designed, HPV-focused educational programmes emerges. Launching such programmes would be especially important for the adolescent population to increase their awareness of the risks associated with HPV infection thus reducing the high incidence of cervical cancer in Hungary in the future.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21939711     DOI: 10.1016/j.vaccine.2011.09.018

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  24 in total

1.  HPV infection awareness and self-reported HPV vaccination coverage in female adolescent students in two German cities.

Authors:  F Samkange-Zeeb; L Spallek; S J Klug; H Zeeb
Journal:  J Community Health       Date:  2012-12

2.  Religion Affects Future Female Doctors' Approach to HPV Vaccination in Czech and Slovak Republics.

Authors:  Jozef Zahumensky; Petra Psenkova; Livia Melnikova; Paula Drabiscakova; Alexandra Nadzamova; Marian Kacerovsky; Ondrej Simetka; Erik Dosedla
Journal:  J Cancer Educ       Date:  2021-03-31       Impact factor: 2.037

3.  Perceptions of Human Papillomavirus (HPV) infection and acceptability of HPV vaccine among men attending a sexual health clinic differ according to sexual orientation.

Authors:  Massimo Giuliani; Maria Fenicia Vescio; Maria Gabriella Donà; Alessandra Latini; Mirko Frasca; Manuela Colafigli; Massimo Farinella; Giovanni Rezza; Antonio Cristaudo
Journal:  Hum Vaccin Immunother       Date:  2016-01-11       Impact factor: 3.452

4.  Awareness and Knowledge Levels of Turkish College Students about Human Papilloma Virus Infection and Vaccine Acceptance.

Authors:  Murat Oz; Nilufer Cetinkaya; Aysen Apaydin; Elmas Korkmaz; Sevda Bas; Emre Ozgu; Tayfun Gungor
Journal:  J Cancer Educ       Date:  2018-04       Impact factor: 2.037

5.  Human papillomavirus vaccine initiation and awareness: U.S. young men in the 2010 National Health Interview Survey.

Authors:  Peng-Jun Lu; Walter W Williams; Jun Li; Christina Dorell; David Yankey; Deanna Kepka; Eileen F Dunne
Journal:  Am J Prev Med       Date:  2013-04       Impact factor: 5.043

6.  Human papillomavirus infection and vaccination: Knowledge and attitudes among young males in Italy.

Authors:  Francesco Napolitano; Paola Napolitano; Giorgio Liguori; Italo Francesco Angelillo
Journal:  Hum Vaccin Immunother       Date:  2016-04-12       Impact factor: 3.452

7.  Comparatively low attendance during Human Papillomavirus catch-up vaccination among teenage girls in the Netherlands: Insights from a behavioral survey among parents.

Authors:  Giedre Gefenaite; Marieke Smit; Hans W Nijman; Adriana Tami; Ingrid H Drijfhout; Astrid Pascal; Maarten J Postma; Bert A Wolters; Johannes J M van Delden; Jan C Wilschut; Eelko Hak
Journal:  BMC Public Health       Date:  2012-07-02       Impact factor: 3.295

8.  Awareness of human papillomavirus and factors associated with intention to obtain HPV vaccination among Korean youth: quasi experimental study.

Authors:  Hae Won Kim
Journal:  BMC Int Health Hum Rights       Date:  2015-02-21

9.  Knowledge of Saudi female university students regarding cervical cancer and acceptance of the human papilloma virus vaccine.

Authors:  Ghadeer K Al-Shaikh; Eman M Almussaed; Amel A Fayed; Farida H Khan; Sadiqa B Syed; Tahani N Al-Tamimi; Hala N Elmorshedy
Journal:  Saudi Med J       Date:  2014-10       Impact factor: 1.484

10.  Human papillomavirus infection: knowledge, attitudes, and behaviors among lesbian, gay men, and bisexual in Italy.

Authors:  Concetta P Pelullo; Gabriella Di Giuseppe; Italo F Angelillo
Journal:  PLoS One       Date:  2012-08-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.